首页|卡孕栓预防产后出血的临床效果研究

卡孕栓预防产后出血的临床效果研究

扫码查看
目的 研究卡前列甲酯栓(商品名:卡孕栓)预防产后出血的临床效果.方法 108 例正常分娩产妇,以数字随机表法分为对照组和观察组,每组 54 例.对照组给予缩宫素预防产后出血,观察组在对照组基础上加用卡孕栓预防产后出血.比较两组产妇产后出血情况、临床疗效、不良反应发生情况以及治疗前后的凝血功能、炎症因子指标水平.结果 观察组产后出血率为 7.4%(4/54),产后 2、24 h出血量分别为(215.13±27.20)、(234.62±29.41)ml;对照组产后出血率为 29.6%(16/54),产后2、24 h出血量分别为(336.32±38.08)、(380.17±42.26)ml.两组产后出血率及产后 2、24 h出血量对比,差异显著(P<0.05).治疗后,观察组产妇纤维蛋白原(FIB)(4.69±0.13)g/L、活化部分凝血活酶时间(APTT)(30.06±1.88)s、凝血酶原时间(PT)(12.06±0.30)s、D-二聚体(D-D)(0.37±0.22)mg/L与对照组的(4.09±0.15)g/L、(32.23±2.10)s、(13.55±0.42)s、(0.63±0.29)mg/L对比,差异显著(P<0.05).治疗后,对照组C反应蛋白(CRP)、白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)分别为(37.82±5.02)mg/L、(34.92±6.27)pg/ml、(28.62±5.71)pg/ml,与观察组的(20.52±4.51)mg/L、(23.02±6.14)pg/ml、(20.16±4.27)pg/ml对比,差异显著(P<0.05).观察组 33 例显效、占比 61.1%,20 例有效、占比 37.0%,1 例无效、占比 1.9%,总有效率 98.1%;对照组 16 例显效、占比 29.6%,27 例有效、占比 50.0%,11 例无效、占比20.4%,总有效率79.6%.观察组总有效率较对照组高,差异显著(x2=9.375,P<0.05).观察组1例胸闷气短,1 例血压升高,1 例面色潮红,合计 3 例,占比 5.56%;对照组 1 例胸闷气短,1 例血压升高,1 例面色潮红,1 例恶心呕吐,合计 4 例,占比 7.41%.两组不良反应发生率对比,差异不显著(x2=0.153,P>0.05).结论 选择卡孕栓+缩宫素预防产后出血,与单一采用缩宫素相比,取得了更为显著的疗效,可借鉴.
Study on clinical effect of Carboprost in prevention of postpartum hemorrhage
Objective To study the clinical effect of carboprost methylate suppository(trade name:Carboprost)in prevention of postpartum hemorrhage.Methods 108 cases of postpartum hemorrhage patients were divided into a control group and an observation group according to digital random table method,each with 54 cases.The control group was given oxytocin to prevent postpartum hemorrhage,and the observation group was given Carboprost to prevent postpartum hemorrhage.The postpartum hemorrhage,clinical efficacy,occurrence of adverse reactions,coagulation function and inflammatory factors before and after treatment were compared between the two groups.Results In the observation group,the postpartum hemorrhage rate was 7.4%(4/54),and the amount of hemorrhage were(215.13±27.20)and(234.62±29.41)ml at 2 and 24 h postpartum;in the control group,the postpartum hemorrhage rate was 29.6%(16/54),and the amount of hemorrhage were(336.32±38.08)and(380.17±42.26)ml at 2 and 24 h postpartum.There were significant differences in the rate of postpartum hemorrhage and amount of hemorrhage at 2 and 24 h postpartum between the two groups(P<0.05).After treatment,the observation group had fibrinogen(FIB)of(4.69±0.13)g/L,activated partial thromboplastin time(APTT)of(30.06±1.88)s,prothrombin time(PT)of(12.06±0.30)s,and D-dimer(D-D)of(0.37±0.22)mg/L,and the difference was significant when compared with(4.09±0.15)g/L,(32.23±2.10)s,(13.55±0.42)s,and(0.63±0.29)mg/L in the control group(P<0.05).After treatment,CRP,IL-8 and TNF-α in the control group were(37.82±5.02)mg/L,(34.92±6.27)pg/ml and(28.62±5.71)pg/ml,and the difference was significant when compared with(20.52±4.51)mg/L,(23.02±6.14)pg/ml and(20.16±4.27)pg/ml in the observation group(P<0.05).In the observation group,33 cases were obviously effective,accounting for 61.1%,20 cases were effective,accounting for 37.0%,1 case was ineffective,accounting for 1.9%,and the total effective rate was 98.1%.In the control group,16 cases were obviously effective,accounting for 29.6%,27 cases were effective,accounting for 50.0%,11 cases were ineffective,accounting for 20.4%,the total effective rate was 79.6%.The total effective rate of the observation group was significantly higher than that of the control group(x2=9.375,P<0.05).The observation group had 1 case of chest tightness and shortness of breath,1 case of elevated blood pressure,1 case of flushing,totaling 3 cases,accounting for 5.56%.The control group had 1 case of chest tightness and shortness of breath,1 case of elevated blood pressure,1 case of flushing,1 case of nausea and vomiting,totaling 4 cases,accounting for 7.41%.There was no significant difference in the incidence of adverse reactions between the two groups(x2=0.153,P>0.05).Conclusion Compared with oxytocin monotherapy,the combination of oxytocin and Carboprost has achieved significant efficacy in the treatment of postpartum hemorrhage,which can be used for reference.

Postpartum hemorrhageCarboprost methylate suppositoryOxytocinCoagulation functionInflammatory factorPrevention

周爽

展开 >

274000 菏泽市妇幼保健院

产后出血 卡前列甲酯栓 缩宫素 凝血功能 炎症因子 预防

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(12)